Articles-RocRock Biotechnology Co., Ltd

Home

About

Overview Team History Awards

Tech

Technical Background Core Tech Pipeline Patents

News

News Articles

Recruitment

Patient Recruitment Trial Facilities R&D Pipeline

Partnerships

Contact

Join

Add Kunshi Jobs Campus

Articles

Protocol for generating human CAR-engineered macrophages by Vpx-containing lentivirus

DNA origami assembled spheroid for evaluating cytotoxicity and infiltration of chimeric antigen receptor macrophage (CAR-M)

Tumor micro-environment induced TRAIL secretion from engineered macrophages for anti-tumor therapy

GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma

Antitumor Activity against BRD4-NUT Fusion Protein by Targeting the BRD4

Enhanced infection efficiency and cytotoxicity mediated by vpx-containing lentivirus in chimeric antigen receptor macrophage (CAR-M)

Structural basis for the inhibition of coronaviral main proteases by ensitrelvir

Long-Read Sequencing Reveals Extensive DNA Methylations in Human Gut Phagenome Contributed by Prevalently Phage-Encoded Methyltransferases

Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants

Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332

Macrophage-based delivery of anti-fibrotic proteins alleviates bleomycin-induced pulmonary fibrosis in mice

Betaine regulates adipogenic and osteogenic differentiation of hAD-MSCs

Suzhou · Shenzhen · Berlin

Technical Background

Patient Recruitment

Patient Recruitment

Trial Facilities

Patient Recruitment

Rock Roc official account

Copyright © 2023 Rock Roc Biotechnology Co., Ltd。All Rights Reserved。苏ICP备2023037904号

0512-67998889(Suzhou)

18051093220(Shenzhen)

Cathy.Lv@rocrockbio.com(Suzhou)

lliangjing@rocrockbio.com (Shenzhen)